Searched for
PHOTODYNAMIC THERAPY
Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...- Gordon Ramsay reveals skin cancer diagnosis and surgery details: What you need to know about basal cell carcinomaGordon Ramsay has disclosed he underwent surgery to remove basal cell carcinoma, a common form of skin cancer, from beneath his left ear. T...
- Sun Pharma shares in focus after USFDA nod for next-gen skin disorder deviceSun Pharma shares: The company announced that the USFDA has approved its enhanced PDT system through the agency’s Real-Time Review Program....
- Stocks in news: BEL, DLF, Vodafone Idea, Arvind Fashion, Bajaj AutoVodafone Idea shares will be in focus after the debt-laden telecom operator approached the Supreme Court challenging the government’s rejec...
- Sun Pharma arm settles case with Biofrontera, to get USD 22.5 mnIn 2018, DUSA Pharmaceuticals had filed a suit at the US District Court of Massachusetts against Biofrontera Inc Biofrontera Bioscience Gmb...
- Do you experience flashes of light, distortion of images, cloudy vision? Screening for retinal diseases early can be beneficialIt is important for everyone to detect drop in vision at the earliest stage.
- Sun Pharma arm gets relief from US court in patent infringement caseThe lawsuit alleged trade secret misappropriation and patent infringement of DUSA's photodynamic therapy patents covering its product.
- Sun Pharma's subsidiary files patent infringement suit against German drug maker BiofronteraDUSA has alleged that Biofrontera defendants misappropriated confidential and trade secret information from DUSA and improperly obtained co...
- Looking for larger acquisitions in key markets: Sun PharmaSun Pharmaceutical Industries today said it is looking forward to larger acquisitions as a part of its expansion plans.
- Sun Pharmaceuticals to buy US-based DUSA for $230 million; stock gainsShares of Sun Pharma moved higher in trade of Friday as sentiment turned bullish after it signed a pact to buy US-based DUSA Pharmaceutical...
- Sun Pharma to buy US-based DUSA Pharmaceuticals for $230 millionUnder the terms of agreement, a 100% subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a pr...
- Sun Pharma to acquire US dermatology company DUSA PharmaSun Pharma is to acquire US-based DUSA Pharmaceuticals, Inc, a dermatology company focused on developing and marketing its Levulan (aminole...
- India Inc on shopping spree, announces deals worth Rs 2,850 croreIn major deals worth Rs 2,850 crore, homegrown companies today announced acquisitions of assets from global firms with Sun Pharma buying DU...
Load More
